15 April 2021 - Australia’s vaccine rollout has been dealt another blow as Novavax confirms manufacturing supply shortages mean it will not meet its target to produce 150 million vaccine doses by mid-year.
The company now says it will not reach full manufacturing capacity until well into the third quarter of this year as it struggles to source bioreactor bags and other raw supplies needed for manufacturing.